Taylor Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18M Hold
3,485
2.3% 10
2026
Q1
$3.21M Hold
3,485
1.94% 11
2025
Q4
$3.75M Sell
3,485
-73
-2% -$69.8K 2.2% 9
2025
Q3
$2.71M Buy
3,558
+65
+2% +$48.4K 1.56% 16
2025
Q2
$2.72M Buy
3,493
+102
+3% +$79.3K 1.7% 14
2025
Q1
$2.8M Buy
3,391
+350
+12% +$291K 1.95% 12
2024
Q4
$2.35M Sell
3,041
-97
-3% -$80.3K 1.63% 15
2024
Q3
$2.78M Sell
3,138
-10
-0.3% -$8.99K 1.92% 9
2024
Q2
$2.85M Sell
3,148
-51
-2% -$40.8K 2.19% 9
2024
Q1
$2.49M Sell
3,199
-1
-0% -$712 1.89% 9
2023
Q4
$1.87M Buy
+3,200
New +$1.87M 1.53% 12

Other funds holding LLY

Taylor Financial Group's LLY Position: Q2 2026 in Review

Taylor Financial Group held its Eli Lilly (LLY) position steady in Q2 2026 at 3,485 shares worth $4.18M. The position accounts for 2.3% of the portfolio, ranked #10.

Taylor Financial Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,123 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Taylor Financial Group held 3,485 shares of Eli Lilly worth $4.18M as of Q2 2026.
  • Taylor Financial Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 2.3% of Taylor Financial Group's portfolio in Q2 2026, its #10 holding.
  • Taylor Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,123 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Taylor Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.